Advertisement
Advertisement

ENGN

ENGN logo

enGene Therapeutics Inc. Common Stock

1.54
USD
Sponsored
+0.10
+6.94%
May 13, 15:56 UTC -4
Closed
exchange

Pre-Market

1.54

0.00
-0.13%

enGene Therapeutics Inc. Common Stock Profile

About

enGene Holdings Inc. is a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues. enGene Holdings Inc., formerly known as Forbion European Acquisition Corp., is based in MONTREAL.

Info & Links

CEO

Ronald H. W. Cooper

Headquarters

4868 RUE LEVY, SUITE 220
SAINT-LAURENT, A8 H4R 2P1, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://engene.com

Auditor

KPMG LLP

Share holders

45

Employees

82

enGene Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

103.03M

Enterprise Value

91.34M

Enterprise Value/EBITDA(ttm)

-0.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.73

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-55.83%

Return on Invested Capital(ttm)

-54.12%

Return on Assets(ttm)

-45.74%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-130.02M

Net Income Available to Common(ttm)

-122.44M

Diluted EPS(ttm)

-2.25

Share Statistics

Beta (5Y Monthly)

-0.06

52-Week Change

-46.53%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

66.99M

Dividend Yield

0.00%

Float4

60.02M

% Held by Insiders

10.40%

% Held by Institutions

64.16%

Balance Sheet

Total Cash(mrq)

276.02M

Total Cash Per Share(mrq)

4.12

Total Debt(mrq)

24.92M

Total Debt/Equity(mrq)

8.85%

Current Ratio(mrq)

11.75%

Quick Ratio(mrq)

11.75%

Book Value Per Share(mrq)

4.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.43

Free Cash Flow(ytd)

-29.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement